208 related articles for article (PubMed ID: 24632529)
21. Changes in levels of D1, D2, or NMDA receptors during withdrawal from brief or extended daily access to IV cocaine.
Ben-Shahar O; Keeley P; Cook M; Brake W; Joyce M; Nyffeler M; Heston R; Ettenberg A
Brain Res; 2007 Feb; 1131(1):220-8. PubMed ID: 17161392
[TBL] [Abstract][Full Text] [Related]
22. Daily monitoring of dopamine efflux reveals a short-lasting occlusion of the dopamine agonist properties of d-amphetamine by dopamine transporter blockers GBR 12909 and methylphenidate.
Ahn S; Phillips AG
ACS Chem Neurosci; 2013 May; 4(5):817-24. PubMed ID: 23586444
[TBL] [Abstract][Full Text] [Related]
23. Dopamine D3 autoreceptor inhibition enhances cocaine potency at the dopamine transporter.
McGinnis MM; Siciliano CA; Jones SR
J Neurochem; 2016 Sep; 138(6):821-9. PubMed ID: 27393374
[TBL] [Abstract][Full Text] [Related]
24. Intermittent access cocaine self-administration produces psychomotor sensitization: effects of withdrawal, sex and cross-sensitization.
Carr CC; Ferrario CR; Robinson TE
Psychopharmacology (Berl); 2020 Jun; 237(6):1795-1812. PubMed ID: 32206828
[TBL] [Abstract][Full Text] [Related]
25. One hour, but not six hours, of daily access to self-administered cocaine results in elevated levels of the dopamine transporter.
Ben-Shahar O; Moscarello JM; Ettenberg A
Brain Res; 2006 Jun; 1095(1):148-53. PubMed ID: 16712814
[TBL] [Abstract][Full Text] [Related]
26. Long-term exposure to oral methylphenidate or dl-amphetamine mixture in peri-adolescent rhesus monkeys: effects on physiology, behavior, and dopamine system development.
Soto PL; Wilcox KM; Zhou Y; Kumar A; Ator NA; Riddle MA; Wong DF; Weed MR
Neuropsychopharmacology; 2012 Nov; 37(12):2566-79. PubMed ID: 22805599
[TBL] [Abstract][Full Text] [Related]
27. Abuse-related effects of dual dopamine/serotonin releasers with varying potency to release norepinephrine in male rats and rhesus monkeys.
Banks ML; Bauer CT; Blough BE; Rothman RB; Partilla JS; Baumann MH; Negus SS
Exp Clin Psychopharmacol; 2014 Jun; 22(3):274-284. PubMed ID: 24796848
[TBL] [Abstract][Full Text] [Related]
28. Anhedonia, Reduced Cocaine Reward, and Dopamine Dysfunction in a Rat Model of Posttraumatic Stress Disorder.
Enman NM; Arthur K; Ward SJ; Perrine SA; Unterwald EM
Biol Psychiatry; 2015 Dec; 78(12):871-9. PubMed ID: 26115790
[TBL] [Abstract][Full Text] [Related]
29. Methylphenidate place conditioning in adolescent rats: an analysis of sex differences and the dopamine transporter.
Cummins ED; Griffin SB; Burgess KC; Peterson DJ; Watson BD; Buendia MA; Stanwood GD; Brown RW
Behav Brain Res; 2013 Nov; 257():215-23. PubMed ID: 24084582
[TBL] [Abstract][Full Text] [Related]
30. Methylphenidate as a reinforcer for rats: contingent delivery and intake escalation.
Marusich JA; Beckmann JS; Gipson CD; Bardo MT
Exp Clin Psychopharmacol; 2010 Jun; 18(3):257-66. PubMed ID: 20545390
[TBL] [Abstract][Full Text] [Related]
31. Increased breakpoints on a progressive ratio schedule reinforced by IV cocaine are associated with reduced locomotor activation and reduced dopamine efflux in nucleus accumbens shell in rats.
Lack CM; Jones SR; Roberts DC
Psychopharmacology (Berl); 2008 Jan; 195(4):517-25. PubMed ID: 17879088
[TBL] [Abstract][Full Text] [Related]
32. Stimulant mechanisms of cathinones - effects of mephedrone and other cathinones on basal and electrically evoked dopamine efflux in rat accumbens brain slices.
Opacka-Juffry J; Pinnell T; Patel N; Bevan M; Meintel M; Davidson C
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():122-30. PubMed ID: 24795175
[TBL] [Abstract][Full Text] [Related]
33. Reduced dopamine terminal function and insensitivity to cocaine following cocaine binge self-administration and deprivation.
Mateo Y; Lack CM; Morgan D; Roberts DC; Jones SR
Neuropsychopharmacology; 2005 Aug; 30(8):1455-63. PubMed ID: 15702135
[TBL] [Abstract][Full Text] [Related]
34. Addiction-related alterations in D1 and D2 dopamine receptor behavioral responses following chronic cocaine self-administration.
Edwards S; Whisler KN; Fuller DC; Orsulak PJ; Self DW
Neuropsychopharmacology; 2007 Feb; 32(2):354-66. PubMed ID: 16541082
[TBL] [Abstract][Full Text] [Related]
35. Isolation rearing impairs the reinforcing efficacy of intravenous cocaine or intra-accumbens d-amphetamine: impaired response to intra-accumbens D1 and D2/D3 dopamine receptor antagonists.
Phillips GD; Howes SR; Whitelaw RB; Robbins TW; Everitt BJ
Psychopharmacology (Berl); 1994 Jul; 115(3):419-29. PubMed ID: 7871084
[TBL] [Abstract][Full Text] [Related]
36. Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens.
Pontieri FE; Tanda G; Di Chiara G
Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12304-8. PubMed ID: 8618890
[TBL] [Abstract][Full Text] [Related]
37. The effects of adolescent methylphenidate self-administration on responding for a conditioned reward, amphetamine-induced locomotor activity, and neuronal activation.
Burton CL; Nobrega JN; Fletcher PJ
Psychopharmacology (Berl); 2010 Feb; 208(3):455-68. PubMed ID: 20020108
[TBL] [Abstract][Full Text] [Related]
38. Amphetamine produces sensitized increases in locomotion and extracellular dopamine preferentially in the nucleus accumbens shell of rats administered repeated cocaine.
Pierce RC; Kalivas PW
J Pharmacol Exp Ther; 1995 Nov; 275(2):1019-29. PubMed ID: 7473128
[TBL] [Abstract][Full Text] [Related]
39. Expression of cocaine sensitization: regulation by the medial prefrontal cortex.
Prasad BM; Hochstatter T; Sorg BA
Neuroscience; 1999; 88(3):765-74. PubMed ID: 10363816
[TBL] [Abstract][Full Text] [Related]
40. Amphetamine self-administration attenuates dopamine D2 autoreceptor function.
Calipari ES; Sun H; Eldeeb K; Luessen DJ; Feng X; Howlett AC; Jones SR; Chen R
Neuropsychopharmacology; 2014 Jul; 39(8):1833-42. PubMed ID: 24513972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
